Operating margin moved 159797 bp lower
Operating margin changed -159797 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
1585.40%→-12.56%3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ATEX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue increased 38.1%
Revenue changed +38.1% from the comparable as-filed period.
$1.4M→$2.0M3 prior comparisons
Net income decreased 99.0%
Net income changed -99.0% from the comparable as-filed period.
$25.2M→$240,0003 prior comparisons
Shares outstanding increased 4.6%
Shares outstanding changed +4.6% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
18,739,790→19,609,7868 prior comparisons
Cash & equivalents increased 180.0%
Cash & equivalents changed +180.0% from the comparable as-filed period.
$41.4M→$116.0M3 prior comparisons
Total assets increased 38.5%
Total assets changed +38.5% from the comparable as-filed period.
$359.6M→$497.9M3 prior comparisons
Current assets increased 176.5%
Current assets changed +176.5% from the comparable as-filed period.
$55.4M→$153.1M3 prior comparisons
SBC / revenue moved 8852 bp lower
SBC / revenue changed -8852 basis points from the comparable as-filed period.
256.14%→167.62%3 prior comparisons
Stockholders' equity increased 54.7%
Stockholders' equity changed +54.7% from the comparable as-filed period.
$184.8M→$285.8M2 prior comparisons
Working capital increased 526.0%
Working capital changed +526.0% from the comparable as-filed period.
$19.4M→$121.5M3 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +165.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$3.1M→$2.0M3 prior comparisons
Operating income changed across a sign change
Operating income changed -101.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$22.5M→-$246,0003 prior comparisons
R&D / revenue moved 1668 bp lower
R&D / revenue changed -1668 basis points from the comparable as-filed period.
78.98%→62.31%3 prior comparisons
Current liabilities decreased 12.2%
Current liabilities changed -12.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$35.9M→$31.5M3 prior comparisons
Working capital / assets moved 1901 bp higher
Working capital / assets changed +1901 basis points from the comparable as-filed period.
5.40%→24.41%3 prior comparisons
Current ratio increased 215.1%
Current ratio changed +215.1% from the comparable as-filed period.
1.54→4.853 prior comparisons
Operating cash-flow margin moved 32588 bp higher
Operating cash-flow margin changed +32588 basis points from the comparable as-filed period.
-221.44%→104.44%3 prior comparisons
Stock-based compensation decreased 9.6%
Stock-based compensation changed -9.6% from the comparable as-filed period.
$3.6M→$3.3M3 prior comparisons
Research & development increased 8.9%
Research & development changed +8.9% from the comparable as-filed period.
$1.1M→$1.2M3 prior comparisons
Operating cash flow / net income changed across a sign change
Operating cash flow / net income changed +6932.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-0.12→8.520 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.